Advertisement

The Applications of Monoclonal Antibodies in Neuro-Oncology

  • E. V. Colapinto
  • Y. S. Lee
  • R. E. McLendon
  • P. A. Humphrey
  • M. R. Zalutsky
  • H. S. Friedman
  • C. N. Pegram
  • S. H. Bigner
  • D. E. Bullard
  • C. J. Wikstrand
  • D. D. Bigner
Chapter
  • 37 Downloads
Part of the Developments in Oncology book series (DION, volume 52)

Abstract

Central nervous system (CNS) malignancies represent one ofthe most devastating forms of cancer. Malignant gliomas, the most commonly occurring primary tumor of the CNS, have a particularly bleak prognosis despite surgery and combined radiation and chemotherapy (1, 2). Immunological approaches to diagnosis and treatment have seemed attractive, but in the past have been frustrated by technological limitations (3, 4). Monoclonal antibody methodology offers major advantages over conventional methods of antiserum production: a practically unlimited source of homogeneous, highly specific reagent which may be prepared using impure or complex antigens. This has led to a new age in neuroimmunology and neuro-oncology, with the potential for better understanding of the basic cell biology of CNS neoplasia, and for improvement in diagnosis, imaging, and therapy.

Key words

Monoclonal antibody glioma glioma-associated antigen xenograft 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Green (S.B.), Byar (D.P.), Walker (M.D.), et al.: Comparisons of carmustine, procarbazine, and high dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep, 67: 121–132 (1983).PubMedGoogle Scholar
  2. 2.
    Walker (M.D.), Alexander (E.), Hunt (W.E.), MacCarty (C.S.), Mahaley (M.S.), Norrel (H.A.), Owens (G.), Ransahoff (J.), Wilson (C.B.), Gehan (E.A.), Strike (T.A.): Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg., 43: 333–343 (1978).Google Scholar
  3. 3.
    Mahaley (M.S.), Mahaley (J.L.), Day (E.D.): Localization of radioantibodies in human brain tumors II. Radioautography. Cancer Res., 2: 779–793 (1965).Google Scholar
  4. 4.
    Mahaley (M.S.), Day (E.D.), Bigner (D.D.): Problems inherent to the in vivo localization of anti-brain tumor antibodies. Ann NY Acad. Sci., 159: 451–460 (1969).CrossRefGoogle Scholar
  5. 5.
    Pegram (C.N.), Eng (L.F.), Wikstrand (C.J.), Mccomb (R.D.), Lee (Y.L.), Bigner (D.D.): Monoclonal antibodies reactive with epitopes restricted to glial fibrillary acidic protein of several species. Neurochem. Pathol., 3: 119–138 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    Mclendon (R.E.), Burger (P.C.), Pegram (C.N.), Eng (L.F.), Bigner (D.D.): The immunohistochemical application of three anti-GFAP monoclonal antibodies to formalin-fixed paraffin-embedded normal and neoplastic brain tissues. J. Neuropathol. Exp. Neurol., 45: 692–703 (1986).PubMedCrossRefGoogle Scholar
  7. 7.
    Vick (W.W.), Bigner (S.H.), Wikstrand (C.J.), Bullard (D.E.), Kemshead (J.), Coakham (H.G.), Schlom (J.), Johnston (W.W.), Bigner (D.D.): The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system. In press, Acta Cytol (1986).Google Scholar
  8. 8.
    Bourdon (M.A.), Wikstrand (C.J.), Furthmayr (H.), Matthews (T.J.), Bigner (D.D.): Human gliomamesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res., 43: 2796–2805 (1983).PubMedGoogle Scholar
  9. 9.
    Wikstrand (C.J.), Mclendon (R.E.), Bullard (D.E.), Fredman (P.), Svennerholm (L.), Bigner (D.D.): Production and characterization of two human glioma xenograft-localizing monoclonal antibodies (Mabs). Cancer Res., 46: 5933–5940 (1986).PubMedGoogle Scholar
  10. 10.
    Wikstrand (C.J.), Mclendon (R.E.), Carrel (S.), Kemshead (J.T.), Mach (J.P.), Coakham (H.B.), Tribolet (N. de), Bullard (D.E.), Zalutsky (M.R.), Bigner (D.D.): Comparative localization of glioma reactive-monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model. In press, J. Neuroimmunol. (1986).Google Scholar
  11. 11.
    Bourdon (M.A.), Coleman (R.E.), Blasberg (R.G.), Groothuis (D.R.), Bigner (D.D.): Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired label and imaging analysis. Anticancer Res, 4:133–140 (1984).PubMedGoogle Scholar
  12. 12.
    Bullard (D.E.), Adams (C.J.), Coleman (R.E.), Bigner (D.D.): In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies. J. Neurosurg., 64: 257–262 (1986).PubMedCrossRefGoogle Scholar
  13. 13.
    Allan (P.M.), Garson (J.A.), Harper (E.L.), Asser (U.), Cookham (H.B.), Brownell (B.), Kemshead (J.T.): Biological characterization and clinical application of a monoclonal antibody recognizing an antigen restricted to neuro-ectodermal tissues. Int. J. Cancer 31: 591–598 (1983).PubMedCrossRefGoogle Scholar
  14. 14.
    Carrel (S.), Accola (R.S.), Karmeyola (A.L.), Mach (J.P.): Common human melanoma associated antigen (s) detected by monoclonal antibodies. Cancer Res 40: 2523–2528 (1980).PubMedGoogle Scholar
  15. 15.
    Coakham (H.B.), Garson (J.A.), Allan (P.M.), Harper (E.L.), Brownell (B.), Kemshead (J.T.), Lane (E.B.): Immunohistological diagnosis of central nervous system tumors using a monoclonal antibody panel. J. Clin Path 38: 165–173 (1985).PubMedCrossRefGoogle Scholar
  16. 16.
    Davies (A.G.), Richardson (R.B.), Bourne (S.P.), Kemshead (J.T.), Coakham (H.B.): Immunolocalisation of human brain tumours. in Bleehan n (E.D.) Tumours of the Brain (Springer-Verlag, 1986).Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht 1987

Authors and Affiliations

  • E. V. Colapinto
    • 1
    • 2
  • Y. S. Lee
    • 2
  • R. E. McLendon
    • 2
  • P. A. Humphrey
    • 2
  • M. R. Zalutsky
    • 4
    • 2
  • H. S. Friedman
    • 2
  • C. N. Pegram
    • 2
  • S. H. Bigner
    • 2
  • D. E. Bullard
    • 3
    • 2
  • C. J. Wikstrand
    • 2
  • D. D. Bigner
    • 2
    • 3
  1. 1.Preuss Laboratory For Brain Tumor Research, AnalDuke University Medical CenterDurhamUSA
  2. 2.Departments of PathologyDuke University Medical CenterDurhamUSA
  3. 3.Department of Surgery (Neurosurgery)Duke University Medical CenterDurhamUSA
  4. 4.Department of RadiologyDuke University Medical CenterDurhamUSA

Personalised recommendations